• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[孕期及给予雌激素、孕激素时子宫肌钙调蛋白的行为及收缩情况]

[Behaviour of uterine muscle calmodulin and contraction during pregnancy and under estrogen, progesterone administration].

作者信息

Takayama T, Iioka H, Kosakai H, Hiraoka K, Moriyama I, Ichijo M

出版信息

Nihon Heikatsukin Gakkai Zasshi. 1985 Apr;21(2):89-93. doi: 10.1540/jsmr1965.21.89.

DOI:10.1540/jsmr1965.21.89
PMID:4087622
Abstract

The calmodulin levels of human and rat myometrium were measured during pregnancy and under estrogen, progesterone administration, and uterine muscle contraction at the same time was also measured. The calmodulin concentration in the uterine muscle was increased as the stage of pregnancy advanced. This increase also intensified the maximum contractility of the uterine muscle together with the increase of growth during pregnancy. The calmodulin levels were increased by the administration of estrogen and this increase was restricted by progesterone. As a result, the adjustment of the calmodulin level by administration of these steroid hormones was found to be a very interesting mechanism for studying the physiology of uterine muscle contractions.

摘要

在妊娠期间以及给予雌激素、孕激素的情况下,对人和大鼠子宫肌层的钙调蛋白水平进行了测定,同时还测量了子宫肌收缩情况。随着妊娠阶段的推进,子宫肌中的钙调蛋白浓度升高。这种升高与妊娠期间生长的增加一起,也增强了子宫肌的最大收缩力。给予雌激素会使钙调蛋白水平升高,而这种升高受到孕激素的限制。结果发现,通过给予这些甾体激素来调节钙调蛋白水平是研究子宫肌收缩生理学的一个非常有趣的机制。

相似文献

1
[Behaviour of uterine muscle calmodulin and contraction during pregnancy and under estrogen, progesterone administration].[孕期及给予雌激素、孕激素时子宫肌钙调蛋白的行为及收缩情况]
Nihon Heikatsukin Gakkai Zasshi. 1985 Apr;21(2):89-93. doi: 10.1540/jsmr1965.21.89.
2
Changes in CD38 expression and ADP-ribosyl cyclase activity in rat myometrium during pregnancy: influence of sex steroid hormones.孕期大鼠子宫肌层中CD38表达及ADP - 核糖基环化酶活性的变化:性甾体激素的影响
Biol Reprod. 2004 Jul;71(1):97-103. doi: 10.1095/biolreprod.103.026245. Epub 2004 Mar 3.
3
Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium.
J Endocrinol. 1983 Apr;97(1):11-9. doi: 10.1677/joe.0.0970011.
4
The effect of in vivo progesterone administration on relaxin-inhibited rat uterine contractions.体内给予孕酮对松弛素抑制的大鼠子宫收缩的影响。
Am J Obstet Gynecol. 1984 Apr 1;148(7):946-50. doi: 10.1016/0002-9378(84)90537-4.
5
[Effects of highly concentrated estrogen and progesterone on the contractile mechanism of the uterine smooth muscles].
Nihon Heikatsukin Gakkai Zasshi. 1986 Feb;22(1):43-51. doi: 10.1540/jsmr1965.22.43.
6
The antagonistic effect of oxytocin and relaxin on rat uterine segment contractility.
Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1644-9. doi: 10.1016/0002-9378(89)90942-3.
7
Increase of myometrial activity correlated with variations in 17 beta-estradiol and progesterone uterine concentrations in mid-term pregnant rat: estrogen agonist effect of 4-hydroxytamoxifen.中期妊娠大鼠子宫肌层活动的增加与子宫中17β-雌二醇和孕酮浓度的变化相关:4-羟基他莫昔芬的雌激素激动剂作用。
C R Acad Sci III. 1997 Jan;320(1):19-25. doi: 10.1016/s0764-4469(99)80082-1.
8
Assessment of myoelectrical signal parameters in estrogen, progesterone, and human chorionic gonadotropin administered in nonpregnant rat myometrium after ovariectomy.卵巢切除术后非妊娠大鼠子宫肌层中给予雌激素、孕激素和人绒毛膜促性腺激素后肌电信号参数的评估。
Fertil Steril. 2008 Jan;89(1):188-98. doi: 10.1016/j.fertnstert.2007.02.020. Epub 2007 May 16.
9
The microRNA (miR)-199a/214 cluster mediates opposing effects of progesterone and estrogen on uterine contractility during pregnancy and labor.微小RNA(miR)-199a/214簇介导孕酮和雌激素在妊娠和分娩期间对子宫收缩的相反作用。
Mol Endocrinol. 2012 Nov;26(11):1857-67. doi: 10.1210/me.2012-1199. Epub 2012 Sep 12.
10
Biochemistry of myometrial contractility.子宫肌层收缩的生物化学
Baillieres Clin Obstet Gynaecol. 1992 Dec;6(4):755-69. doi: 10.1016/s0950-3552(05)80187-7.